The Microbiota, a major health topic yet to be fully explored and considered

The role played by the microbiota in human health has been of growing interest for the last decade. Ground-breaking research about this topic is booming. It has led to a better understanding of how over a trillion microorganisms, which live in our gut (bacteria, viruses, parasites, and fungi), interact with the digestive system and form a complex ecosystem that plays a fundamental role in human health and diseases.

However, there remains a lot to be explored.

Biocodex Microbiota Foundation for sciences advance and better care of human microbiota

As a world-renowned leader in microbiota research and a pioneer in probiotic treatments, Biocodex launched in 2017 a Foundation dedicated to enhancing scientific knowledge about the human microbiota, improving our understanding of microbiota, disseminating this knowledge as widely as possible and eventually, contributing to improving human health.
Each year, the Biocodex Microbiota Foundation awards annual grants to innovative scientific research projects that explore the role of microbiota and, in particular, the impact of its imbalance on the occurrence or evolution of various pathologies. To do so, the Foundation gathers both international and national boards of independent experts who select the most innovative fundamental or applied research projects to be awarded grants.

In 2021, Biocodex Microbiota Foundation launched Henri Boulard Award

To foster its commitment to improving global health, the Biocodex Microbiota Foundation launches in 2021 the Henri Boulard Award.

Henri Boulard is the famous French microbiologist who discovered the yeast Saccharomyces boulardii in the 1920s in Indochina and its virtues against diarrhoea. The Henri Boulard Award honors this memory, and it is dedicated to improving the management of disorders associated with microbiota.

This award supports projects initiated at a local level through education, new infrastructure, awareness campaigns, farming projects, etc. From water purification projects to health education programs, the project has to address a local unmet medical need in the country and improve a population’s health.

About Biocodex

Founded in France in 1953, Biocodex is an independent multinational pharmaceutical company that studied and demonstrated the beneficial effects of a probiotic yeast, Saccharomyces boulardii CNCM I-745® in the field of gastroenterology.

For more information, please visit

Our values


To enable the Foundation to effectively fulfill its role and responsibilities, Biocodex and Biocodex Microbiota Foundation are two separate and legally unrelated entities whose operations are completely independent.


Trust in the scientific community, which guarantees that Biocodex Microbiota Foundation’s ambition is built exclusively on the authority of knowledge.


The projects we support aim at moving health forward for everyone, everywhere.

Long-term vision

The Foundation has a long-term vision, investing in the abilities and potential of scientific people to improve human health.


Marie Emmanuelle Le Guern

Biocodex Microbiota Foundation Chairman, Biocodex Laboratory Compiègne, France

Murielle Escalmel

Biocodex Microbiota Foundation General Delegate, Laboratory Biocodex Gentilly, France

Maxime Prost à la Denise

Medical Affairs Director, France Division, Biocodex Laboratory Gentilly, France

Lynne Mc Farland

Infectious Diseases Epidemiologist, Seattle, USA

Aude Boclé

General Manager Biocodex, Warsaw, Poland

Xavier Roux

Head of Microbiology Department, Biocodex Laboratory Compiègne, France

Alain Marié

CEO of Wonder Search company, Paris, France

Harry Sokol

Professsor of Gastroenterology, Saint-Antoine Hospital, Paris, France


Caroline Lachowsky

Science journalist at RFI
and producer of the show “Autour de la Question”, Paris, France

Patrick De Boever

Research and Innovation Manager
of the Centre of Excellence Microbial Systems Technology
at the University of Antwerp, Belgium

International scientific committee

Harry Sokol

President of the committee,
Professor of Gastroenterology, Saint-Antoine Hospital, Paris, France

Joel Doré

Research Director & Scientific Director, INRAE & Metagenopolis, Jouy en Josas, France

Francisco Guarner

Consultant of Gastroenterology, Barcelona, Spain

C. Högenauer

Gastroenterologist, Medical University of Graz, Austria

Magnus Simren

Professor of Gastroenterology , Senior Consultant, University of Gothenburg, Sweden

N. Segata

Professor and Director of Computational Metagenomics, University of Trento, Italy

E. Verdu

Professor of Gastroenterology, McMaster University - Hamilton, Canada

G. Wu

Professor of Gastroenterology, Philadelphia, USA